To the Editor:

We read with interest the recent article by Repici et al[@bib1] in which the authors discuss the challenges of endoscopy in the time of the COVID-19 pandemic and suggest measures to minimize the risk of transmission in endoscopy units. We would appreciate having the authors' insight on some of the aspects that will be discussed below.

Since the coronavirus infection (SARS-COV-2) has become a worldwide health problem, many society guidelines have been published, dealing with contamination risks and prevention of infection during endoscopic procedures, including the correct use and removal of personal protective equipment (PPE). It is now recognized that endoscopic procedures in COVID-19 patients are highly infecting to all involved healthcare personnel.[@bib1] ^,^ [@bib2]

From the peak of the pandemic to the moment when most people acquire immunity against SARS-COV-2 (either by infection or by an effective vaccine), endoscopy units will have to resume their daily activities around the globe. It will be challenging to repeat the huge numbers of routine endoscopic procedures performed before the COVID-19 pandemic, considering the time spent for the correct use and removal of PPE and the shortage of rooms equipped with negative pressure ventilation, just to mention a few limitations. In this sense, we would like to have the authors' insights on the strategies they will adopt when they face this moment of transition. In addition to the measures to triage patients suspected of having COVID-19 infection before endoscopic procedures, would it be advisable to perform immunologic tests in healthcare personnel in whom (at least symptomatic) COVID-19 did not develop? In theory, healthcare personnel whose test results are negative for both serum IgM antibody and SARS-COV-2 polymerase chain reaction (PCR) from nasal and oral swabs, and whose test results are positive for serum IgG antibody against the virus, are immune to the SARS-COV-2 infection.[@bib3], [@bib4], [@bib5], [@bib6], [@bib7], [@bib8] One possible strategy would be to perform antibody tests (IgM and IgG) first, followed by PCR in those with positive results for IgG. Based on the results, it would be easier to organize the endoscopy unit personnel working scales, assigning the susceptible workers to sectors where contact with patients is less intense. If it is possible and available, performing PCR in patients who will undergo endoscopic procedures could also help to define the proper management and better organize the routine of the endoscopy unit.[@bib9]

It is noteworthy that the performance of such tests should not replace the use of PPE or the active search for symptoms of SARS-COV-2, such as fever, cough, and dyspnea, before the endoscopic examination as mentioned above.[@bib1] ^,^ [@bib2]
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